Blame US Trade Policy for Sky High Drug Prices Jayati Ghosh

Jayati Ghosh argues that it is ironic that a US administration attempting to lower drug prices for Americans is also pushing for changes in intellectual property rules in ways that would allow multinationals to hugely hike pharmaceutical prices in foreign markets like India.

Click here for full article.

(This article was originally published in the Project Syndicate on June 10, 2019)